FDA orders recall of dengue vaccine

THE Food and Drug Administration (FDA) has ordered the recall of a controversial dengue vaccine from the market because of the health risk it poses to its recipients.

“The FDA immediately directed Sanofi to SUSPEND the sale/distribution/marketing of Dengvaxia and cause the WITHDRAWAL of Dengvaxia in the market pending compliance with the directives of the FDA,” according to the advisory issued late Monday.